(Total Views: 335)
Posted On: 06/24/2021 3:59:38 PM
Post# of 1460

LGVN has successful Phase 1 clinical trial. They think that their drug slows cognitive decline.
However, it depends on bone marrow cells from "young healthy adults." That's going to be kinda hard to source in quantity.
https://www.yahoo.com/finance/news/longeveron...11964.html
However, it depends on bone marrow cells from "young healthy adults." That's going to be kinda hard to source in quantity.
https://www.yahoo.com/finance/news/longeveron...11964.html

